LOW DOSE CONTINUOUS THERAPY WITH DASATINIB SIGNIFICANTLY IMPACT ON SURVIVAL OF PATIENTS WITH CHRONIC MYELOID LEUKAEMIA (CML) RESISTANT OR INTOLERANT TO IMATINIB. RESULTS FROM A REAL LIFE-BASED ITALIAN MULTICENTER RETROSPECTIVE STUDY ON 114 UNSELECTED PATIENTS

Autor:	Visani, G., Breccia, M., Gozzini, A., Specchia, G., Montefusco, E., Morra, E., Annunziata, M., Luciano, L., Camera, A., Cavazzini, Francesco, Stagno, F., Di Raimondo, F., Pregno, P., Santini, V., Piccaluga, P., Pacilli, M., Pungolino, E., Angelucci, E. Usala E., Cuneo, Antonio, Ferrara, F., Crugnola, M., Binotto, G., Maino, E., Latagliata, R., Nicolini, G., Barulli, S., Loscocco, F., Alimena, G., Isidori, A.
Jazyk:	angličtina
Rok vydání:	2010
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3709::b5718cf64a817f3b66ce19e9f850e911 http://hdl.handle.net/11392/1401535 Zobrazit plný text záznamu